Internal Medicine, Endocrinology, Diabetes, & Metabolism · Saint Paul, MN
NPI
1538692835
Since 2017
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
225 Smith Ave N Ste 300
Saint Paul, MN, 55102
Phone (651) 241-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$289K
23,012 services
Medicare patients, 2024
619
Average age 73
Drug cost, 2024
$1.5M
4,228 prescriptions
Company payments, 2025
$325
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irfaan A Abid was code J3111 (injection, romosozumab-aqqg, 1 mg), 15,015 times for 15 patients. In total Irfaan A Abid billed 23,012 services in 136 codes, and Medicare paid $289K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 15,015 | 15 | $8.49 | $127K |
| J0897 Injection, denosumab, 1 mg | Office | 3,120 | 34 | $20.45 | $64K |
| 36415 Venipuncture Blood Collection | Office | 474 | 389 | $8.51 | $4,033 |
| 99214 Office E&M - Established | Office | 394 | 280 | $87.96 | $35K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 379 | 298 | $12.02 | $4,557 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 175 | 35 | $4.01 | $702 |
| 84443 Clinical Chemistry | Office | 135 | 117 | $16.35 | $2,207 |
| 96372 Injection Administration | Office | 129 | 53 | $11.26 | $1,453 |
| 80048 Clinical Chemistry | Office | 119 | 110 | $8.22 | $978 |
| 83036 Blood Count | Office | 119 | 90 | $9.25 | $1,101 |
| 80053 Clinical Chemistry | Office | 118 | 112 | $10.35 | $1,221 |
| 82306 Clinical Chemistry | Office | 110 | 104 | $29.01 | $3,191 |
| 83735 Clinical Chemistry | Office | 86 | 80 | $6.57 | $565 |
| 80061 Clinical Chemistry | Office | 79 | 78 | $12.98 | $1,025 |
| 95251 Test - Miscellaneous | Office | 67 | 39 | $25.84 | $1,731 |
By year: 2022 $20K for 1,190 services; 2023 $258K for 23,092 services; 2024 $289K for 23,012 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 474 | 389 | $8.51 | $4,033 |
| 84443 Clinical Chemistry | 135 | 117 | $16.35 | $2,207 |
| 83036 Blood Count | 119 | 90 | $9.25 | $1,101 |
| 80048 Clinical Chemistry | 119 | 110 | $8.22 | $978 |
| 80053 Clinical Chemistry | 118 | 112 | $10.35 | $1,221 |
| 82306 Clinical Chemistry | 110 | 104 | $29.01 | $3,191 |
| 83735 Clinical Chemistry | 86 | 80 | $6.57 | $565 |
| 80061 Clinical Chemistry | 79 | 78 | $12.98 | $1,025 |
| 83880 Clinical Chemistry | 61 | 52 | $38.47 | $2,347 |
| 82784 Immunoassay | 51 | 31 | $9.11 | $465 |
Medicare prescription drug claims, 2024
In 2024, the drug Irfaan A Abid prescribed most often to Medicare patients was Levothyroxine Sodium, with 701 prescriptions and refills. In total Irfaan A Abid wrote 4,228 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 701 | 1,909 | 211 | $10K |
| Ozempic Semaglutide | 262 | 366 | 50 | $339K |
| Atorvastatin Calcium Generic | 230 | 628 | 83 | $2,877 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 166 | 393 | 60 | $28K |
| Metformin Hcl Generic | 150 | 413 | 55 | $1,778 |
| Methimazole Generic | 123 | 343 | 41 | $2,304 |
| Jardiance Empagliflozin | 118 | 295 | 35 | $167K |
| Ezetimibe Generic | 103 | 283 | 36 | $3,006 |
| Glipizide Er Glipizide | 99 | 287 | 34 | $1,899 |
| Alendronate Sodium Generic | 99 | 258 | 32 | $1,079 |
| Glipizide Generic | 95 | 240 | 27 | $1,976 |
| Metformin Hcl Er Metformin Hcl | 88 | 244 | 32 | $1,419 |
| Hydrocortisone Generic | 88 | 190 | 17 | $3,451 |
| Lisinopril Generic | 86 | 229 | 27 | $866 |
| Rosuvastatin Calcium Generic | 83 | 241 | 37 | $1,068 |
Brand drugs: 1,733 claims; generic drugs: 2,307 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Irfaan A Abid $325 ($325 in general payments such as food, travel and fees) from 1 company. The largest payer was Chiesi USA, Inc. with $325.
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 1 | $325 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.